Literature DB >> 1884779

Antibiotic treatment of rickettsiosis, recent advances and current concepts.

D Raoult1.   

Abstract

The author reviews the recent advances in the treatment of Mediterranean Spotted Fever and Q fever. In mediterranean spotted fever (M.S.F.), in vitro and preliminary in vivo data support the place of quinolones and josamycin in the treatment of M.S.F. In children josamycin could become the first choice drug as well as in pregnant woman. In Q fever chronic disease should be treated using a combination of antibiotic (doxycycline + quinolones) for a minimum of 3 years.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1884779     DOI： 10.1007/bf00145677

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  43 in total

1.  Tetracycline in the treatment of "Q" fever.

Authors:  O W POWELL; K P KENNEDY; M McIVER; H SILVERSTONE
Journal:  Australas Ann Med       Date:  1962-08

2.  Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.

Authors:  F Gudiol; R Pallares; J Carratala; F Bolao; J Ariza; G Rufi; P F Viladrich
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Action of streptomycin in experimental infection with Q fever.

Authors:  R J HUEBNER; G A HOTTLE; E B ROBINSON
Journal:  Public Health Rep       Date:  1948-03-19       Impact factor: 2.792

4.  Coxiella burnetii infection of a vascular prosthesis.

Authors:  D Raoult; P Piquet; H Gallais; C de Micco; M Drancourt; P Casanova
Journal:  N Engl J Med       Date:  1986-11-20       Impact factor: 91.245

5.  Q fever endocarditis treated with trimethoprim and sulphamethoxazole.

Authors:  R Freeman; M E Hodson
Journal:  Br Med J       Date:  1972-02-12

6.  Q fever endocarditis in the United States.

Authors:  R C Kimbrough; R A Ormsbee; M Peacock; W R Rogers; R W Bennetts; J Raaf; A Krause; C Gardner
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

7.  [Rickettsiaceae infections and fluoroquinolones].

Authors:  A Bertrand; F Janbon; O Jonquet; J Reynes
Journal:  Pathol Biol (Paris)       Date:  1988-05

8.  Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo.

Authors:  D Raoult; P Roussellier; G Vestris; V Galicher; R Perez; J Tamalet
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

9.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

10.  Chronic Q fever endocarditis.

Authors:  M P Varma; A A Adgey; J H Connolly
Journal:  Br Heart J       Date:  1980-06
View more
  8 in total

1.  Epitope mapping of the Sta58 major outer membrane protein of Rickettsia tsutsugamushi.

Authors:  R Lachumanan; S Devi; Y M Cheong; S J Rodda; T Pang
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

2.  Steroids treatment of granulomatous hepatitis complicating Coxiella burnetii acute infection.

Authors:  M Crespo; B Sopeña; J Bordón; J de la Fuente; M Rubianes; C Martinez-Vázquez
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

3.  In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; E Scoulica; A Psaroulaki; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

4.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

5.  In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; A Psaroulaki; D Kofterithis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.

Authors:  Ioanna Spyridaki; Anna Psaroulaki; Iosif Vranakis; Yannis Tselentis; Achilleas Gikas
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

7.  Targeted knockout of the Rickettsia rickettsii OmpA surface antigen does not diminish virulence in a mammalian model system.

Authors:  Nicholas F Noriea; Tina R Clark; Ted Hackstadt
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

8.  Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.

Authors:  Marissa S Fullerton; Punsiri M Colonne; Amanda L Dragan; Katelynn R Brann; Richard C Kurten; Daniel E Voth
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.